Public-registry site landscape for NCT05683496, a Thyroid Eye Disease study sponsored by ACELYRIN Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05683496 (registry record) |
| Sponsor | ACELYRIN Inc. |
| Condition(s) | Thyroid Eye Disease |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 11 |
| Site countries | United States, Australia |
Eichor generates a preliminary site-risk snapshot for NCT05683496 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →